WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

WMT

96.95

-0.33%↓

COST

981.86

-0.4%↓

TGT

102.71

+0.54%↑

KR

70.22

+0.69%↑

STZ

169.2

-0.89%↓

Search

Afya Ltd (Class A)

Geschlossen

BrancheKonsumgüter defensiv

16.27 -1.15

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

16.2

Max

16.47

Schlüsselkennzahlen

By Trading Economics

Einkommen

102M

252M

Verkäufe

87M

936M

KGV

Branchendurchschnitt

12.348

27.852

Dividendenrendite

1.3

Gewinnspanne

26.913

EBITDA

173M

480M

Empfehlungen

By TipRanks

Empfehlungen

Sell

12-Monats-Prognose

+21.3% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.30%

3.43%

Nächstes Ergebnis

14. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-132M

1.6B

Vorheriger Eröffnungskurs

17.42

Vorheriger Schlusskurs

16.27

Nachrichtenstimmung

By Acuity

50%

50%

61 / 150 Ranking in Consumer defensive

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Afya Ltd (Class A) Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Juli 2025, 15:46 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250 Million Private Placement

9. Juli 2025, 23:44 UTC

Market Talk

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Global Equities Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 20:26 UTC

Ergebnisse

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9. Juli 2025, 19:18 UTC

Market Talk

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9. Juli 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9. Juli 2025, 18:31 UTC

Market Talk

Some Fed Officials Supported Considering July Cut -- Market Talk

9. Juli 2025, 17:07 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk -2-

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9. Juli 2025, 16:14 UTC

Akquisitionen, Fusionen, Übernahmen

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9. Juli 2025, 16:12 UTC

Market Talk

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9. Juli 2025, 16:08 UTC

Market Talk

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9. Juli 2025, 15:31 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250M Private Placement

9. Juli 2025, 15:31 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9. Juli 2025, 15:27 UTC

Market Talk

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9. Juli 2025, 14:36 UTC

Akquisitionen, Fusionen, Übernahmen

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9. Juli 2025, 14:31 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9. Juli 2025, 14:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

9. Juli 2025, 14:26 UTC

Market Talk

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Peer-Vergleich

Kursveränderung

Afya Ltd (Class A) Prognose

Kursziel

By TipRanks

21.3% Vorteil

12-Monats-Prognose

Durchschnitt 20.67 USD  21.3%

Hoch 23.5 USD

Tief 19 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Afya Ltd (Class A) – Dist angeboten haben.

Rating-Konsens

By TipRanks

Sell

3 ratings

0

Buy

2

Halten

1

Sell

Technischer Score

By Trading Central

18.968 / 19.56Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

61 / 150 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.